|
Volumn 134, Issue 5, 2001, Pages 387-395
|
Update in addiction medicine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3,4 METHYLENEDIOXYMETHAMPHETAMINE;
4 HYDROXYBUTYRIC ACID;
ALCOHOL;
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
CANNABIS;
COCAINE;
FLUNITRAZEPAM;
KETAMINE;
METHADONE;
METHAMPHETAMINE;
NALTREXONE;
NICOTINE;
OPIATE;
TETRAHYDROCANNABINOL;
ADDICTION;
BEHAVIOR THERAPY;
CLINICAL TRIAL;
COGNITIVE THERAPY;
DOSE RESPONSE;
DRUG TOLERANCE;
DRUG WITHDRAWAL;
ENVIRONMENTAL FACTOR;
GROUP THERAPY;
HEREDITY;
HUMAN;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PSYCHOSOCIAL CARE;
PSYCHOTHERAPY;
REVIEW;
SUBSTANCE ABUSE;
TOBACCO;
TREATMENT OUTCOME;
TWINS;
|
EID: 0035814978
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-134-5-200103060-00011 Document Type: Review |
Times cited : (7)
|
References (15)
|